Clinical trial
Clopidogrel Reloading in Patients With Non-ST Elevation Acute Coronary Syndrome Undergoing PCI on Chronic Clopidogrel Therapy. Results of the ARMYDA RELOAD ACS (Antiplatelet Therapy for Reduction of MYocardial Damage During Angioplasty in Acute Coronary Syndrome) Randomized Trial.
NCT01572129 is registered in ClinicalTrials.gov with Campus Bio-Medico University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clopidogrel Reloading in Patients With Non-ST Elevation Acute Coronary Syndrome Undergoing PCI on Chronic Clopidogrel Therapy. Results of the ARMYDA RELOAD ACS (Antiplatelet Therapy for Reduction of MYocardial Damage During Angioplasty in Acute Coronary Syndrome) Randomized Trial.
- Lead sponsor
- Campus Bio-Medico University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- November 30, 2011
- Completion date
- Not reported
- Enrollment
- 240 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.